Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Myriad Genetics Eyes GeneSight
Myriad Genetics Inc. (NASDAQ: MYGN), which specializes in molecular diagnostics and personalized medicine, started off August with the acquisition of privately-held Assurex Health Inc., an informatics-based, personalized medicine company that specializes in pharmacogenomics, a study of the genetic factors that influence an individual’s response to drug treatments, for behavioral health and chronic pain conditions. Assurex was sold for an upfront payment of $225 million, and is also eligible to receive up to $185 million in additional performance-based milestones. The acquisition gives Myriad access to GeneSight®, one of the fasting growing diagnostic tests in a multi-billion dollar market.... Read More »Scintilla Goes Deep into Pain Management
Scintilla Pharmaceuticals, Inc., a subsidiary of Sorrento Therapeutics Inc. (NASDAQ: SRNE), is spending up to $270 million to expand its pain management pipeline. On August 8, Scintilla announced its purchase of SCILEX Pharmaceuticals, Inc. for an upfront payment of $70 million. Scilex’s lead product candidate, ZTildo™ (lidocaine patch 1.8%) is being developed for the treatment of intractable cancer pain. In July 2015, SCILEX filed a new drug application (NDA) for ZTildo™, and is planning an NDA re-submission for a potential FDA action date in mid-2017. SCILEX’ product pipeline includes line extensions of ZTildo™ as well as other novel patch technologies in development. The patch... Read More »Recent Health Care Deals, week ending 08.12.2016
AcquirerTargetPrice EQT PartnersPress Ganey$2.35 billion Carter Validus Mission Critical REIT IIHPI portfolio$116.5 million Allergan plcForSight VISIONS$95 million Scintilla PharmaceuticalsSCILEX Pharmaceuticals $70 million ZymeWorks Inc. License to HuTARG platform$65... Read More »Patient Experience Data Draws Big Money
EQT, a Swedish private equity firm with approximately €30 billion in raised capital, announced it was taking Press Ganey Holdings (NYSE: PGND) private with a purchase price of $2.35 billion, or $40.50 a share. Press Ganey made its mark by offering patient experience solutions to measure and analyze data collected directly from patients, including patient experience insights measured through several electronic modes; and caregiver engagement solutions comprising physician, nurse and, employee alignment and engagement solutions. It also provides clinical and quality solutions, such as Nursing Quality Indicators, a program that collects data on a set of nursing-sensitive process, structure,... Read More »First Half of 2016 Shows Strength in M&A
Ever since the rally in health care mergers and acquisitions began in 2014, we’ve been waiting for the inevitable slam-on-the-brakes quarter. That rally was sparked by the advent of newly insured families and individuals entering the healthcare market, beginning on January 1, 2014. Thanks to the Affordable Care Act, passed in 2010, health care M&A topped 1,000 transactions that year and has never looked back. Isn’t it about time for the party to end? Not according to our data for the first six months of 2016, compared with the same period in 2014 and 2015. (But if you read our monthly M&A roundup on page 18, you may have second thoughts.) In the first half of 2016, deal volume... Read More »Don’t Let IT Blow Up a Good Deal
Our Editor, Lisa Phillips, sits down with Owen Grohman, Director of Services at Worldwide Supply, to talk about healthcare information technology, and how it can make or break an acquisition. Read More »MEDNAX Makes 10
MEDNAX (NYSE:MD) hit the big 10 in August 2016, with its tenth acquisition of the year. The serial acquirer picked up privately-held Associated Anesthesiologists of Reno, P.C., the largest anesthesia practice in northern Nevada, offering anesthesia care across a broad range of subspecialties, including orthopedic, obstetric, pediatric and cardiac and critical care. MEDNAX continues to capitalize on anesthesiology practices’ need to become a part of a larger organization in order to meet the data and technology capabilities that hospitals are asking of them, and this purchase marks its sixth anesthesiology acquisition of the year. Outside of anesthesiology, MEDNAX acquired privately-held... Read More »Recent Health Care Deals, week ending 08.05.2016
AcquirerTargetPrice Teva Pharmaceutical IndustriesAnda Inc.$500 million Pfizer Inc. Bamboo Therapeutics Inc. $193 million Molina HealthcareMedicare assets from Aetna and Humana$117 million Cantel Medical Corp.Accutron Inc. $52.5 million CareTrust REIT, Inc.The Oaks$6.9... Read More »Home Health’s Hot Summer Streak
With 38 deals so far in 2016, home health care continues to be a hot topic. Three deals were announced in the first week of August alone, with Dallas-based Epic Health Services being the acquirer for two of these deals. Epic Health Services, a portfolio company of Webster Capital, provides pediatric skilled nursing, therapy, developmental, enteral and respiratory services. On August 1st, the company announced the acquisition of Pediatric Special Care Inc., the only pediatric nursing and home medical equipment company in Michigan. It offers private-duty nursing services and a full range of high-tech medical equipment. Three days later, Epic Health acquired privately-held Spring View Home... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
